Skip to main content
NC State Home
Pharmaceutical offshoring makes recalls more costly with more quality headaches

Biopharmaceutical Supply Chain>Pharmaceutical Supply Chain

Apr 8, 2021

Vaccines are the Utility Needed for the Global Economy

In an article in Politico, the (somewhat) obvious point is made that the Biden administration is finally recognizing that there is not enough manufacturing capacity in the US to produce…

May 21, 2020

Healthcare Strategic Stockpile Management Remains a Big Challenge

Beginning in 2015 the National Academies of Sciences, Engineering and Medicine led a standing committee to inform Strategic National Stockpile (SNS) decision-making. This committee included “…state and local public health…

Feb 9, 2020

Coronavirus reminds us to review supply chain continuity plans

The rapid escalation of the Corona virus has now devastated China and other regions, resulting in more than 800 deaths and more than 37,000 cases worldwide.  The most critical outcome…

Apr 1, 2019

Risk Management in Contract Pharmaceutical Development: Contract Research Part 2

The second installation in our series on contract management research published by MBA students from my online Contract Management class is by Julia Condit, and focuses on the challenges of…

Sep 26, 2018

Changing Executive Mindsets on Global Product Integrity: The Fight Against Counterfeiting Is Here to Stay

I recently interviewed the Director of Brand Protection at a large pharmaceutical company, who shared with me the timeline around how his company gradually shifted and changed its views on…

Jul 16, 2018

Pharmaceutical offshoring makes recalls more costly with more quality headaches

I spent some time working on a study of how offshoring impacts quality issues, specifically product recalls, with a number of researchers at the University of Palermo, led by Manfredi…